Posts by tag
androgen deprivation therapy
Round-up of prostate and breast cancer studies from ESMO 2021
The 2021 Congress of the European Society for Medical Oncology (ESMO), held 16‒21 September, featured studies that are likely to impact a broad spectrum of clinical practice. We summarise some of the findings that could change treatments for two of…
Wake-up call to offer equal access to life-prolonging treatments in metastatic prostate cancer
Less than one third of men with metastatic castration-sensitive prostate cancer (mCSPC) received established treatment intensification by 2018 that had been demonstrated to extend survival. The US study evaluating real-world utilization of advanced therapies, abstract 5073, released in advance of…
Hormone therapy for prostate cancer may shield from COVID-19
[caption id="attachment_9949" align="alignright" width="324"] Abnormal Lipid Metabolism in Prostate Cancer (Source: National Cancer Institute Purdue University Center for Cancer Research. Image by Ji-Xin Cheng)[/caption] Prostate cancer patients treated with androgen-deprivation therapies (ADTs) seem to have a lower risk of SARS-CoV-2…